Trial Profile
A Pilot Study of ReNu Hip Injection: Monitoring the Response of Hip Function and Pain in Patient With Osteoarthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jan 2020
Price :
$35
*
At a glance
- Drugs Amniotic cell therapy-NuCel (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Nutech Medical
- 13 Jan 2020 Status changed from active, no longer recruiting to completed.
- 21 Aug 2019 Planned End Date changed from 1 Jun 2019 to 1 Oct 2019.
- 21 Aug 2019 Planned primary completion date changed from 1 Jun 2019 to 1 Oct 2019.